JXHL1600057 | 预充式醋酸兰瑞肽缓释注射液 | lanreotide acetate | Injection | Chemical Drugs | Import Drug Application | 2016-05-10 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma | Certificate Issued | 2017-03-16 | view |
JYHB2000001 | 银杏叶片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-02-13 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Beaufour Ipsen Industrie;Ipsen Consumer Healthcare | Certificate Issued | 2020-03-12 | view |
JYHB1200112 | 银杏叶片 | | Tablet | Chemical Drugs | Supplementary Application | 2012-02-10 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Beaufour Ipsen Industrie;Ipsen Pharma | Certificate Issued | 2016-11-10 | view |
JYHB2001524 | 银杏叶片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-08-20 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Beaufour Ipsen Industrie;Ipsen Consumer Healthcare | Filed | 2020-09-01 | view |
JYHB2000871 | 银杏叶片 | | Tablet | Chemical Drugs | Supplementary Application | 2020-06-28 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Beaufour Ipsen Industrie;Ipsen Consumer Healthcare | Certificate Issued | 2020-09-02 | view |
JYHB2100052 | 银杏叶提取物片 | Ginkgo biloba | Tablet | Chemical Drugs | Supplementary Application | 2021-01-16 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Beaufour Ipsen Industrie;Ipsen Consumer Healthcare | In Review | 2021-01-15 | view |
JYHB2000252 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs | Supplementary Application | 2020-03-21 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Certificate Issued | 2020-06-02 | view |
JYHB2001773 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs | Supplementary Application | 2020-09-14 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Filed | 2020-09-29 | view |
JYHB2000206 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs(5.1) | Supplementary Application | 2020-03-16 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Certificate Issued | 2020-05-26 | view |
JXHL2000296 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs(5.1) | Import Drug Application | 2020-11-09 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma | In Review | 2020-11-07 | view |
JYHB2000251 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs | Supplementary Application | 2020-03-21 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Certificate Issued | 2020-06-02 | view |
JYHB2001772 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs | Supplementary Application | 2020-09-14 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Filed | 2020-09-29 | view |
JYHB2000209 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs(5.1) | Supplementary Application | 2020-03-16 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Certificate Issued | 2020-05-26 | view |
JYHB2000250 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs | Supplementary Application | 2020-03-21 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Certificate Issued | 2020-06-02 | view |
JYHB2000207 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs(5.1) | Supplementary Application | 2020-03-16 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Certificate Issued | 2020-05-26 | view |
JYHB2001774 | 醋酸兰瑞肽缓释注射液(预充式) | lanreotide acetate | Injection | Chemical Drugs | Supplementary Application | 2020-09-14 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Ipsen Pharma Biotech | Filed | 2020-09-29 | view |
JYHB1901177 | 蒙脱石混悬液 | diosmectite | Suspension | Chemical Drugs | Supplementary Application | 2019-10-15 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Pharmatis;Ipsen Consumer Healthcare | In Review | 2019-10-14 | view |
JXHL1800117 | 蒙脱石混悬液 | diosmectite | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2018-09-05 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma | Certificate Issued | 2018-11-12 | view |
JXHS1900089 | 蒙脱石混悬液 | diosmectite | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2019-07-11 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd;Ipsen Pharma;Pharmatis | In Review | 2019-07-10 | view |
J0300414 | 蒙脱石散剂 | diosmectite | Powder | Chemical Drugs | License Renew | 2003-08-27 | 博福-益普生(天津)制药有限公司 | Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | 2003-12-19 | view |